Search results
AbbVie (NYSE:ABBV) Shares Down 0.5% After Analyst Downgrade
ETF DAILY NEWS· 1 day agoAbbVie Inc. (NYSE:ABBV – Get Free Report) shares fell 0.5% on Monday after Barclays lowered their price target on the stock from $195.00 to $187.00. AbbVie
Earnings call: AbbVie surpasses Q1 expectations, announces CEO transition By Investing.com
Investing.com· 3 days agoThe earnings call also marked a significant leadership transition, with CEO Rick Gonzalez announcing...
AbbVie (ABBV) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 6 days agoImage source: The Motley Fool. AbbVie (NYSE: ABBV) Q1 2024 Earnings Call Apr 26, 2024, 9:00 a.m. ET Contents: Prepared Remarks Questions and Answers Call...
Better Dividend Stock: AbbVie or Johnson & Johnson?
Motley Fool via Yahoo Finance· 4 days agoThere are many dividend stocks on the market, but few are as prominent as AbbVie (NYSE: ABBV) and Johnson & Johnson (NYSE: JNJ). These companies have...
Drugmaker AbbVie expects Humira volume erosion to worsen
Reuters via Yahoo News· 6 days ago(Reuters) -AbbVie expects a drop in sales volumes of its blockbuster arthritis drug Humira to deepen...
AbbVie (ABBV) Beats Q1 Earnings and Revenue Estimates
Zacks via Yahoo Finance· 6 days agoAbbVie (ABBV) delivered earnings and revenue surprises of 2.21% and 2.65%, respectively, for the...
The top pharmaceutical companies by R&D expenditure
Pharmaceutical Technology via Yahoo Finance· 3 hours agoMerck & Co- $30.5bn Merck & Co’s revenues reached $60.1bn in FY 2023, with R&D investments peaking at $30.5bn. Displaying a staggering 126% growth...
AbbVie Inc: An Exploration into Its Intrinsic Value
GuruFocus.com via Yahoo Finance· 2 days agoIn this article, we will take a look into AbbVie Inc's (NYSE:ABBV) DCF analysis, a reliable and data-driven approach to estimating its intrinsic value....
Investors Take AbbVie To The Woodshed. But Its Woes Are 'Unfounded.'Investors Take AbbVie To The...
Investor's Business Daily· 3 days agoOn Friday, AbbVie beat first-quarter expectations, largely on the back of its immunology franchise....
AbbVie earnings beat by $0.04, revenue topped estimates
Investing.com· 6 days agoAbbVie earnings beat by $0.04, revenue topped estimates
